In some individuals with germline TP53 mutations over the age of 70, no cancers are detected over their lifetimes, and the incidence of cancers in Li-Fraumeni patients with TP53 mutations over 70 years old falls to a rate below the general population, which is increasing dramatically after 60–70 years of age [24–27]. This evidence concerns the gene TP53 and cancer.